TEKLA CAPITAL MANAGEMENT
Tekla Capital Management LLC is a registered investment adviser based in Boston, Massachusetts, and is currently the investment adviser for two closed-end equity funds, H&Q Healthcare Investors and H&Q Life Sciences Investors. The Funds invest in growth equities, both public and private, in the healthcare and life sciences industries.
TEKLA CAPITAL MANAGEMENT
Social Links:
Industry:
Finance Financial Services Health Care Venture Capital
Founded:
1986-06-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Nginx PHP
Similar Organizations
Alethea Capital Management
Alethea Capital Management is an SEC-registered investment advisor founded in March of 2011
Current Advisors List
Jeffrey Allen Bailey Vice Chairman Board of Trustees @ Tekla Capital Management Board_member 2020-10-01
Current Employees Featured
Jason C. Akus
Jason C. Akus Senior Vice President, Research @ Tekla Capital Management Senior Vice President, Research
Daniel R. Omstead
Daniel R. Omstead President and Chief Executive Officer @ Tekla Capital Management President and Chief Executive Officer
Jenny Fowler
Jenny Fowler Fund Administration Senior Associate @ Tekla Capital Management Fund Administration Senior Associate
Christian M. Richard
Christian M. Richard Senior Vice President, Research @ Tekla Capital Management Senior Vice President, Research 2015-03-01
Kolotioloma Silue
Kolotioloma Silue Manager of Fund Administration @ Tekla Capital Management Manager of Fund Administration
Alan Kwan
Alan Kwan Senior Analyst @ Tekla Capital Management Senior Analyst
William R. Hite
William R. Hite Senior Analyst, Research @ Tekla Capital Management Senior Analyst, Research
Joshua A.W. Mosberg
Joshua A.W. Mosberg Senior Analyst, Research @ Tekla Capital Management Senior Analyst, Research 2015-11-01
Peter Savitscus
Peter Savitscus Head of Trading @ Tekla Capital Management Head of Trading
Amanda Birdsey-Benson
Amanda Birdsey-Benson Senior Analyst @ Tekla Capital Management Senior Analyst
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-05-10 | Invetx | Tekla Capital Management investment in Series B - Invetx | 60.5 M USD |
2022-04-06 | MoonLake Immunotherapeutics | Tekla Capital Management investment in Post-IPO Equity - MoonLake Immunotherapeutics | 115 M USD |
2022-02-10 | Arkuda Therapeutics | Tekla Capital Management investment in Series B - Arkuda Therapeutics | 64 M USD |
2022-02-07 | Endeavor BioMedicines | Tekla Capital Management investment in Series B - Endeavor BioMedicines | 101 M USD |
2021-11-29 | Quell Therapeutics | Tekla Capital Management investment in Series B - Quell Therapeutics | 156 M USD |
2021-11-09 | Arbor Biotechnologies | Tekla Capital Management investment in Series B - Arbor Biotechnologies | 215 M USD |
2021-11-03 | Parthenon Therapeutics | Tekla Capital Management investment in Series A - Parthenon Therapeutics | 65 M USD |
2021-10-21 | ReCode Therapeutics | Tekla Capital Management investment in Series B - ReCode Therapeutics | 80 M USD |
2021-07-27 | Aristea Therapeutics | Tekla Capital Management investment in Series B - Aristea Therapeutics | 63 M USD |
2021-06-23 | ImmuneID | Tekla Capital Management investment in Series A - ImmuneID | 50 M USD |